SCHEMBL30254352

SCHEMBL30254352

O=C(Nc1c(F)cccc1I)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 3/20 0.41
PTGS2 P35354 2/20 0.41
ALDH1A1 P00352 1/20 0.40
MEN1 O00255 2/20 0.38
JAK2 O60674 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
KLK7 P49862 1/20 0.38
TLR8 Q9NR97 2/20 0.38
PDK1 Q15118 2/20 0.37
PDK2 Q15119 2/20 0.37
PDK3 Q15120 2/20 0.37
PDK4 Q16654 2/20 0.37
RAB9A P51151 1/20 0.37
ANO1 Q5XXA6 1/20 0.36
TLR7 Q9NYK1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23885108 1.00 L3MBTL1 (0.42) L3MBTL1KMT2APTGS2ALDH1A1MEN1
SCHEMBL10625596 0.87 KMT2A (0.52) L3MBTL1KMT2AALDH1A1MEN1JAK2
SCHEMBL2338360 0.80 PTGS2 (0.50) KMT2APTGS2ALDH1A1MEN1RAB9A
SCHEMBL20050944 0.79 HDAC1 (0.52) L3MBTL1KMT2AALDH1A1JAK2TP53
SCHEMBL31312589 0.79 MAP2K1 (0.36) L3MBTL1ALDH1A1JAK2TP53MAPT
SCHEMBL15569990 0.79 PDK1 (0.55) L3MBTL1KMT2APTGS2JAK2MAPT
SCHEMBL20560179 0.79 KMT2A (0.43) KMT2APTGS2ALDH1A1MEN1RAB9A
SCHEMBL4607513 0.78 ALB (0.49) L3MBTL1KMT2AALDH1A1MEN1JAK2
SCHEMBL4607670 0.77 L3MBTL1 (0.47) L3MBTL1KMT2AALDH1A1MEN1MAPT
SCHEMBL22262468 0.76 MAPT (0.48) L3MBTL1KMT2AALDH1A1MEN1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705296-A1 HETEROARYLINDOLE INHIBITORS OF APOL-1 OmniAB, Inc. (US) 2026-03-11 EP disclosed
WO-2024242846-A1 HETEROARYLINDOLE INHIBITORS OF APOL-1 OMNIAB, INC. (US) 2024-11-28 WO disclosed
EP-4125914-A1 PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2023-02-08 EP disclosed